Shanghai Yizhong Pharmaceutical Co., Ltd. Report for the first quarter of 2024
Announcement of Resolutions of the Fifth Meeting of the 2nd Board of Supervisors of Shanghai Yizhong Pharmaceutical Co., Ltd.
Announcement of Shanghai Yizhong Pharmaceutical Co., Ltd. on voluntary disclosure of plans to invest in the construction of a screening and design platform for novel small molecule drugs
Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders of Shanghai Yizhong Pharmaceutical Co., Ltd.
2023 Annual Shareholders' Meeting Lawyers' Opinions
Announcement of Resolutions of the Fifth Meeting of the Second Board of Directors of Shanghai Yizhong Pharmaceutical Co., Ltd.
Shanghai Yizhong_2023 Annual General Meeting of Shareholders Meeting Materials
Announcement of Shanghai Yizhong Pharmaceutical Co., Ltd. on the 2023 profit distribution and capital reserve transfer plan
Announcement of Shanghai Yizhong Pharmaceutical Co., Ltd. on the 2024 remuneration plan for directors, supervisors and senior management
Announcement of Shanghai Yizhong Pharmaceutical Co., Ltd. on renewing the employment of an accounting firm
Announcement of Shanghai Yizhong Pharmaceutical Co., Ltd. on revising and adding some corporate governance systems
Audit Committee Implementation Rules (April 2024)
Board of Directors Rules of Procedure (April 2024)
Special meeting system for independent directors
Related transaction management system
Announcement of Shanghai Yizhong Pharmaceutical Co., Ltd. on matters relating to the adjustment of the 2022 restricted stock incentive plan
Announcement of Resolutions of the Fourth Meeting of the 2nd Board of Supervisors of Shanghai Yizhong Pharmaceutical Co., Ltd.
Announcement of Shanghai Yizhong Pharmaceutical Co., Ltd. and its subsidiaries on the use of idle own funds for cash management
Special Report on the Deposit and Use of Funds Raised by Shanghai Yizhong Pharmaceutical Co., Ltd. in 2023
Announcement of Shanghai Yizhong Pharmaceutical Co., Ltd. on the by-election of independent directors of the second board of directors of the company and the adjustment of the board special committee
No Data